Healthcare providers continue to consider safety profiles, contraindications, drug interactions, and patient-specific factors when selecting diabetes medicines. Monitoring and appropriate prescribing remain important aspects of DPP-4 inhibitor use. Greater attention to treatment safety is influencing clinical decision-making.
The Dipeptidyl Peptidase-4 Inhibitors Market is expected to reach...
